The influence of autonomic neurohormonies on the immunologic release of fl-glucuronidase (EC 3.2
in the extracellular discharge of fl-glucuronidase without any loss of cell viability, as indicated by the failure of incubated cells to take up eosin Y or to release cytoplasmic lactate dehydrogenase (EC 1.1.1.27). Epinephrine reduced the release of f3-glucuronidase from neutrophils in the presence of zymosan during 2-30 min of incubation and elicited a concomitant elevation of adenosine 3': 5'-monophosphate levels. Propranolol, a ,B-adrenergic receptor antagonist, but not phentolamine, an a-adrenergic receptor antagonist, blocked both actions of epinephrine. Acetylcholine stimulated the release of j3-glucuronidase, but not lactate dehydrogenase, and provoked a concomitant elevation of guanosine 3': 5'-monophosphate levels.
Atropine, a muscarinic receptor antagonist, but not hexamethonium, a ganglionic blocker, inhibited both actions of acetylcholine. Interaction of neutrophils and zymosan particles resulted in an elevation of guanosine 3': 5'-monophosphate levels within 2 min. These data suggest that intracellular guanosine 3': 5'-monophosphate may be involved in mediating the immunologic release of lysosomal enzymes from human neutrophils whereas adenosine 3': 5'-monophosphate may inhibit enzyme release. Moreover, autonomic neurohormones appear to be capable of modulating lysosomal enzyme release by virtue of their capacity to elevate neutrophil cyclic nucleotide levels.
Lysosomal enzymes are prominent mediators of acute inflammation (1, 2) and cartilage degradation (3, 4) , and are selectively discharged from polymorphonuclear leukocytes during phagocytosis of, or cell-surface contact with, various immunologic reactants (5) (6) (7) (8) . In fact, the connective-tissue injury that results from the accumulation of granulocytes is probably a direct consequence of the extracellular release of lysosome granule constituents (9, 10) . Recent studies indicate that contact of human granulocytes with altered immunoglobulin G-treated cartilage results in the extrusion of lysosomal neutral proteases and consequent degradation of the cartilage proteoglycan matrix (8) .
In view of the potential destructive capacity of human granulocyte lysosomal contents, inhibition of the immunologic discharge of such deleterious substances is of fundamental importance in attenuating inflammation and connective tissue destruction. Several agents, including colchicine, vinblastine, prostaglandin El, and adenosine 3': 5'-monophosphate (cyclic AMP) have been reported to reduce lysosomal enzyme release from granulocytes (11) . Recent studies in this laboratory indicate that certain catecholamines such as epinephrine inhibit, whereas cholinergic agents such as acetylcholine stimulate, the immunologic release of lysosomal enzymes from human mixed leukocytes (12, 13) . These findings suggest that autonomic neurohormones possess the capacity to influence the course of the inflammatory process.
In the light of our previous findings that certain autonomic neurohormones and cyclic nucleotides are capable of influencing lysosomal enzyme release from leukocytes (12, 13) , studies were designed to elucidate the relationship between the cellular actions of autonomic agents and the intracellular concentrations of cyclic nucleotides. The expression of cellular actions of certain adrenergic and cholinergic agents by cyclic AMP and guanosine 3': 5'-monophosphate (cyclic GMIP), respectively, is well documented (14) (15) (16) . Therefore, concentrations of cyclic AMP and cyclic GMIP in purified human neutrophils were monitored during cell contact with phagocytosable particles, and the time course of changes in both Blglucuronidase release and cyclic nucleotide levels in the response of neutrophils to epinephrine and acetylcholine was determined.
MATERIALS AND METHODS
Isolation of Human Neutrophils. Human neutrophils were isolated from fresh heparinized venous blood drawn from healthy volunteers by a modification of the glass bead column chromatographic procedure described by Rabinowitz (17 Gilman (20) . Levels of cyclic GMP were measured essentially according to the radioimmunoassay of Steiner et al. (21) . Neutrophil samples, which were processed after rapid freezing of individual incubation mixtures containing the cells, were acidified and extracted with ether as described (16 granulocytes during cell contact with phagocytosable (5-7, 12, 13) and nonphagocytosable (6-8) immune reactants has been reported. Epinephrine (1 ,uM) markedly reduced the immunologic release of ,-glucuronidase activity from human neutrophils by zymosan particles during 2-30 min of incubation at 370 (Fig. 1) . Previous studies indicated that exogenous cyclic AMP can inhibit lysosomal enzyme release from human phagocytic leukocytes (5, 12) . Therefore, in view of the knowledge that epinephrine is capable of stimulating the formation of cyclic AMP in diverse tissues, measurements were made of neutrophil levels of cyclic AMP in the absence and presence of epinephrine. Epinephrine elicited a time-dependent elevation of cyclic AMP levels in neutrophils during cell contact with zymosan (Fig. 2) . Incubation of cells with zymosan alone did not alter cyclic AMP levels. In the absence of phagocytosable particles, epinephrine produced only a small increase in cyclic AMP levels.
These data illustrate a close temporal correlation between inhibition of lysosomal enzyme release and elevation of cyclic AMP levels by epinephrine in human neutrophils during cell interaction with immunologic reactant. The association between these two cellular events is even more evident with the finding that propranolol (1 pM), a ,B-adrenergic receptor antagonist, blocked the actions of epinephrine on both enzyme release and cyclic AMP levels ( Table 1) . Phenotolamine (1 pM), an a-adrenergic receptor antagonist, did not block but, in fact, enhanced both effects of epinephrine. All of these findings suggest that cyclic AMP is capable of mediating the actions of epinephrine in neutrophils. This view is supported by the observations that cyclic AMP and its dibutyryl analog (10-0.1 ,uM) reduced the immunologic release of j-glucuronidase ( Table 2) .
Response of Human Neutrophils to Acetylcholine and Cyclic GMP. Acetylcholine (1 pAM) markedly increased the discharge of fl-glucuronidase, but not lactate dehydrogenase, from human neutrophils during 2-30 min of incubation at 370 with serum-treated zymosan particles (Fig. 3) . In the absence of zymosan no significant enzyme release was produced by acetylcholine. In view of previous observations that added cyclic GMP can accelerate lysosomal enzyme release from human mixed leukocytes (12) and purified neutrophils (13) and that acetylcholine can stimulate tissue formation of cyclic GMP (15, 16) , the effect of acetylcholine on neutrophil levels of cyclic GMP was studied. Acetylcholine provoked a significant elevation of cyclic GMP levels in neutrophils during cell contact with zymosan (Fig. 4) . In the absence of acetylcholine the zymosan particles elicited a time-dependent elevation of neutrophil cyclic GMP. The concomitant increase in enzyme release and cyclic GMP levels in neutrophils elicited by acetylcholine indicates that a close association of these two cellular events exists. (12, 13) and cyclic GMP levels (cyclic GMP levels were reduced from 10.7 i 1.5 to 5.6 i 0.8 pmoles/106 cells at 2 min of incubation). Atropine did not affect zymosan-induced enzyme release or elevation of cyclic GMP at 2 and 5 min of incubation in the absence of acetylcholine. These data suggest that cyclic GMP is capable of mediating these actions of acetylcholine on neutrophils. Indeed, exogenous cyclic GMP and two of its analogs (10-0.1 AM) enhanced the immunologic discharge of f3-glucuronidase from human neutrophils ( (11) (12) (13) .
In most mammalian biologic systems, acetylcholine elicits pharmacologic effects that are often opposite in action to those of epinephrine. Such a relationship is also evident in human neutrophils with regard to the immunologic release of lysosomal enzymes. Acetylcholine stimulates whereas epinephrine inhibits enzyme release. The finding that acetylcholine elevates neutrophil levels of cyclic GMP implies that this nucleotide may mediate the stimulatory action of acetylcholine on phagocytic enzyme release. Indeed, when atropine was used to inhibit the elevation of cyclic GMP levels by acetylcholine, the enhancing effect of acetylcholine on fl-glucuronidase release was also blocked. Further, cyclic GMP and some of its structural analogs stimulate release of lysosomal enzylnes from human neutrophils. We have demonstrated previously the capacity of cyclic GMP to stimulate the release of lysosome granule enzymes from human mixed granulocytes (12) .
The presence of both cyclic AMP and cyclic GMP, as well as the cellular machinery for elevating the levels of either nucleotide, in human neutrophils endows this cell type with the capacity to exercise a bidirectional control of lysosomal enzyme release. The opposing actions of cyclic AMP and cyclic GMP on phagocytic enzyme release represent the first clear demonstration of a bioregulatory concept of "Yin Yang" as originally proposed by Goldberg (22) , whereby these two cyclic nucleotides directly elicit oppositional effects. In view of the concomitant elevation of cyclic GMP levels and stimulation of f3-glucuronidase release during contact of neutrophils with immunologic reactant, it appears reasonable to consider that cyclic GMP is involved intimately in triggering the immunologically provoked extracellular discharge of lysosomal enzymes from human neutrophils.
At this time the precise intracellular mechanism by which cyclic nucleotides modulate enzyme release is unknown. Cyclic. AMP and cyclic GMP, however, have been shown to influence markedly the permeability of the lysosome membrane to enzyme proteins (23) (24) (25) . Moreover, cyclic nucleotides have been shown many times to bind to and activate nucleotidedependent protein kinases. Therefore, activation of specific protein kinases by cyclic AMP or cyclic GMP, resulting in the phosphorylation of one or more cellular components, may play a part in regulating lysosomal enzyme release. Such phosphorylation reactions could alter the physical and/or functional properties of lybosomes and thereby interfere with specific functions of these organelles, such as peripheral migration or fusion of granules with heterophagic vacuoles or the plasma membrane.
The data in this report suggest that the immunologic discharge of lysosomal enzymes from human neutrophils is mediated by neutrophilic cyclic GMP, and that autonomic neurohormones are capable of modulating enzyme release via the selective elevation of intracellular levels of the appropriate cyclic nucleotide.
